Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus)

Table 1 Demographic and Disease Characteristics

Patient Number	Gender	Age (Years)	Cancer diagnosis	Years since first diagnosis	Location of metastases	Days from interview to death
1	Female	45	Mucoepidermoid carcinoma (head and neck)	14.7	Lymph nodes	28
2	Male	50	Squamous carcinoma (head and neck)	0.7	Lymph nodes	Alive-709
3	Female	54	Anaplastic thyroid carconoma	10.8	Lungs/liver/bone	21
4	Female	47	Malignant Melanoma	12.7	Eye/breast/liver/chest wall/lung	664
5	Female	47	Metastatic Breast carcinoma	6.6	Chest wall/bone	241
6	Female	60	Metastatic Breast carcinoma	2.7	Chest wall /lungs /retroperitoneum	Alive-529
7	Male	32	Soft tissue sarcoma	0.5	Right lower extremity	96
8	Male	56	Neuroendocrine islet cell tumor	2.4	Liver/face/neck/ Scalp	44
9	Female	56	Metastatic Breast carcinoma	2.7	Chest wall/ left supraclavicular skin/ intrabdomen	142
11	Male	42	Malignant melanoma	6.4	Liver/lung/spleen	Alive-368
12	Male	64	Klatskin's tumor	1.4	Abdomen	171
13	Female	76	Metastatic Breast carcinoma	26.9	Lung/bone/liver	136
14	Female	55	Malignant melanoma	1.8	Axilla /lung /liver	Alive-242
15	Female	48	Metastatic breast carcinoma	2.8	Neck /Chest Wall /Brain	Alive-242
16	Female	46	Soft tissue sarcoma	3.9	Lung/skin/breast/ retroperitoneal	Alive-227
17	Male	70	Squamous carcinoma (head and neck)	9.7	Head/neck	Alive-207

ISSN: 1477-7525